×
GoodRx Holdings Price to Free Cash Flow Ratio 2019-2024 | GDRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GoodRx Holdings price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
View More
GoodRx Holdings Price to Free Cash Flow Ratio 2019-2024 | GDRX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
GoodRx Holdings price to free cash flow ratio from 2019 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$125.1B
Cencora (COR)
$45B
ICON (ICLR)
$25B
DiDi Global (DIDIY)
$19B
Avantor (AVTR)
$18.4B
Natera (NTRA)
$15.7B
Revvity (RVTY)
$15.4B
Viatris (VTRS)
$14.2B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$12.5B
Medpace Holdings (MEDP)
$11.2B
Charles River Laboratories (CRL)
$10.6B
Sonic Healthcare (SKHHY)
$8.8B
Doximity (DOCS)
$7.4B
Bausch + Lomb (BLCO)
$7B
HealthEquity (HQY)
$6.8B
PACS (PACS)
$6.2B
Organon (OGN)
$5.1B
Life Times (LTH)
$4.9B
Sotera Health (SHC)
$4.7B
Surgery Partners (SGRY)
$4.1B
Concentras Parent (CON)
$3B
BrightSpring Health Services (BTSG)
$2.5B
Ardent Health Partners (ARDT)
$2.4B
Progyny (PGNY)
$2.2B
Alignment Healthcare (ALHC)
$2.2B
Premier (PINC)
$2.1B
Ryman Healthcare (RYHTY)
$1.9B
AMN Healthcare Services Inc (AMN)
$1.8B
Agilon Health (AGL)
$1.6B